Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Genomic data and its application to clinical use, molecular tumor boards with diverse expertise can provide guidance to oncologists and patients seeking to implement personalized genetically targeted therapy in practice.
- Start Year
- End Year
- National Cancer Institute Grant No. P30 CA006973 to the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Visit Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
- Study design
- Patients' cohort
- Follow Up
- A median follow-up of 7 months
Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. JCO Precis Oncol. 2017;2017:PO.16.00046. doi: 10.1200/PO.16.00046. Epub 2017 May 31.
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
Availability of data and biosamples
No coverage data about the variables classifications are available.